Chief Financial Officer
Tue, May 23, 2023
May 23
exercised or converted securities in ACLX
22,428 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +438.60% (+7,724 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology